Cargando…
pH-Responsive Hybrid Nanoassemblies for Cancer Treatment: Formulation Development, Optimization, and In Vitro Therapeutic Performance
Current needs for increased drug delivery carrier efficacy and specificity in cancer necessitate the adoption of intelligent materials that respond to environmental stimuli. Therefore, we developed and optimized pH-triggered drug delivery nanoassemblies that exhibit an increased release of doxorubic...
Autores principales: | Teixeira, Patrícia V., Adega, Filomena, Martins-Lopes, Paula, Machado, Raul, Lopes, Carla M., Lúcio, Marlene |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966415/ https://www.ncbi.nlm.nih.gov/pubmed/36839648 http://dx.doi.org/10.3390/pharmaceutics15020326 |
Ejemplares similares
-
Natural Compounds: Co-Delivery Strategies with Chemotherapeutic Agents or Nucleic Acids Using Lipid-Based Nanocarriers
por: Teixeira, Patrícia V., et al.
Publicado: (2023) -
Hybrid Nanoassemblies from Viruses and DNA Nanostructures
por: Ojasalo, Sofia, et al.
Publicado: (2021) -
Future Perspectives in Detecting EGFR and ALK Gene Alterations in Liquid Biopsies of Patients with NSCLC
por: Ferreira, Daniela, et al.
Publicado: (2021) -
Hybrid Amyloid Quantum Dot Nanoassemblies to Probe Neuroinflammatory Damage
por: Chiang, Wesley, et al.
Publicado: (2023) -
Nucleic acid nanoassembly-enhanced RNA therapeutics and diagnosis
por: Zhao, Mengnan, et al.
Publicado: (2023)